This week, Congress reached a bipartisan healthcare deal as part of a larger $1.2 trillion spending bill, combining funding ...

Bristol Myers Squibb hasn’t had much luck with its efforts to develop cancer treatments called T cell engagers. But the pharmaceutical company isn’t done pursuing this type of targeted cancer therapy, ...

A report published by MedCity News and sponsored by Smarter Technologies offers fresh insights from revenue cycle management executives and staff. The AI Index in RCM report shares what they like and ...

French medtech startup Naox Technologies this month became the first company to receive FDA 510(k) clearance for an in-ear electroencephalogram (EEG) device — a move that could shift brain monitoring ...

Wellcome Leap and Medicines360 launched a partnership last week that aims to accelerate maternal health tools globally. San Diego-based Wellcome Leap helps build and fund programs to improve human ...

Cancer drugs are always popular biotech investments, but autoimmune disease also figures prominently in the startup ...

Alcohol use disorder kills more Americans than opioids or car crashes. Yet for decades, medicine ignored an FDA-approved pill that significantly reduces relapse risk and heavy-drinking days. That pill ...

President Donald Trump unveiled the Great Healthcare Plan to lower drug costs and insurance premiums, but healthcare ...

GLP-1s have been the blockbuster biopharma story of the past few years, and these effective weight loss drugs will forever be the watershed moment in the long fight against obesity. Not to be ...

Private equity activity in the global healthcare sector set a new record last year with an estimated $191 billion in deal value, according to new data from Bain & Company. Healthcare remains one of PE ...

Surescripts, a health intelligence network, unveiled a new product on Tuesday called Script Corner, which aims to improve price transparency for medications. The new product is in partnership with ...